Healy Center for ALS Presents the Lalji Award for Innovative Healing
The Sean M. Healey & AMG Center for ALS awards the fourth annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing to Richard Robitaille, Ph.D.
The Sean M. Healey & AMG Center for ALS awards the fourth annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing to Richard Robitaille, Ph.D.
Sean M. Healey & AMG Center for ALS at Mass General awards sixth annual Sean M. Healey International Prize for Innovation in ALS to Leigh Hochberg, M.D., Ph.D. & the BrainGate Consortium Team
Sabrina Paganoni, MD, PhD, speaks about the HEALEY ALS Platform Trial, a novel approach to testing new therapeutics for ALS patients.
New research findings suggest that changes in DNA methylation could serve as both a biomarker for identifying individuals at risk of depression and a possible marker of biological resilience against mental illness.
Alicia-Huerta, Miriam Udler and Josep M Mercader, Investigators at the Diabetes Unit and Center for Genomic Medicine at Massachusetts General Hospital and at the Broad Institute of MIT and Harvard, and colleagues are lead and senior authors of a recently published paper in Nature Genetics, Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes
Jordan Ball, MS, RDN, LDN, provides a guide to help you savor the holidays in a way that honors both your health and happiness.
Researchers generated the largest and most comprehensive spatially resolved single-cell census and molecular architecture of the first trimester human placenta.
Alison Kane, RDN, LDN, provides a recipe for Tuscan kale & white bean soup.
In this issue, we highlight research updates from the Albers Lab at Massachusetts General Hospital. The Albers lab combines chemical biology, genetics, and computational methods in human brain tissue and mouse models to understand how neurodegenerative diseases develop.
Discover how a new rapid test developed at Mass General Brigham is enabling doctors to diagnose brain tumors faster, including Rohan’s high-grade glioma.
Members of the media can reach the News and Public Affairs staff by phone.